Загрузка...
Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints
OBJECTIVES: Isavuconazole, a novel triazole antifungal agent, has broad-spectrum activity against Aspergillus spp. and other pathogenic fungi. The isavuconazole exposure–response relationship in experimental invasive pulmonary aspergillosis using galactomannan index (GMI) suppression as a marker of...
Сохранить в:
| Опубликовано в: : | J Antimicrob Chemother |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4896411/ https://ncbi.nlm.nih.gov/pubmed/27084921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw098 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|